hero section gradient
15 handpicked stocks

The Great Energy Realignment

Recent US tariff threats against buyers of Russian oil and a major new energy deal with the EU are redirecting global energy demand. This creates a prime opportunity for U.S. energy producers and exporters poised to meet Europe's growing needs.

Author avatar

Han Tan | Market Analyst

Published on July 31

Your Basket's Financial Footprint

Market capitalisation breakdown for the basket provided by the user, summarising dominance of largest constituents.

Key Takeaways for Investors:
  • Large-cap concentration generally implies greater stability, lower volatility, and closer broad-market tracking.
  • Suitable as a core, long-term holding rather than a speculative, high-growth trade.
  • Expect steady, long-term value appreciation rather than rapid, short-term explosive gains.
Total Market Cap
  • XOM: $480.51B

  • EOG: $57.90B

  • EPD: $66.60B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Geopolitical pressures and new trade agreements are creating a massive shift in global energy flows. As Europe moves away from Russian oil due to US tariff threats, American energy producers are perfectly positioned to fill this gap. The new US-EU energy deal worth $750 billion represents a structural change that could benefit US companies for years to come.

2

What You Need to Know

This group focuses on the entire US energy export supply chain - from upstream oil and gas producers to midstream pipeline operators and LNG export facilities. These companies are positioned to serve a large, secure European market with sustained high demand. The theme captures both immediate opportunities and long-term structural advantages.

3

Why These Stocks

These stocks were handpicked by professional analysts based on their strategic positioning in the trans-Atlantic energy bridge. Each company plays a crucial role in either producing or transporting American energy to European markets, making them prime beneficiaries of this historic realignment in global energy trade.

Why You'll Want to Watch These Stocks

🌊

Historic Energy Shift

We're witnessing a once-in-a-generation realignment of global energy flows. As Europe pivots away from Russian oil, American producers are stepping in to fill a massive $750 billion opportunity.

🚀

Secured European Demand

Unlike volatile spot markets, this represents long-term, contracted demand from a stable, wealthy trading partner. These companies now have visibility into sustained revenue growth for years ahead.

Infrastructure Advantage

The US already has the production capacity and export infrastructure in place. These companies don't need to build from scratch - they're ready to capitalise on increased demand immediately.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions